Bausch Health Companies Inc. (BHC)
NYSE: BHCHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BHC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.30B
- Forward P/E
- 1.47
- EPS (TTM)
- -$3.01
- Dividend yield
- None
- Ex-dividend date
- Nov 10, 2010
- 52-week range
- 4.33 – 8.00
- Day range
- 6.02 – 6.32
- Volume / Avg
- 1.98M / 3.26M
- Beta
- —
- Shares outstanding
- 373.99M
- Next earnings
- Oct 28, 2026
52-week range
BHC stock today
Shares of Bausch Health Companies (BHC) finished higher on Oct 7 at $6.15, a gain of 2.16% or $0.13 per share, versus the S&P 500's 0.22% decline. Shares are 23.1% below their 52-week high of $8.00, set on Jan 7, 2026 and 42.0% above the 52-week low of $4.33, in the middle of the past year's range. BHC is down 11.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 3.8%.
Bausch Health Companies has posted a net loss over the last twelve months (EPS of -$3.01), so its P/E ratio is not meaningful. The company is scheduled to report Sep/2026 results on Oct 28 after the market closes; analysts expect EPS of $1.08.
Summary generated from market data by MetaCap's automated system. Methodology
About Bausch Health Companies
Company profileBausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Thomas J. Appio
- Headquarters
- Laval, QC
- Employees
- 20,300
- Website
- bauschhealth.com
Analyst forecast
ForecastConsensus (7 analysts)
hold
Avg. price target
$7.50+21.95%
- Strong buy 0
- Buy 0
- Hold 7
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 28, 2026
- EPS estimate
- $1.08
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $1.00
- Ex-dividend date
- Nov 10, 2010
BHC news
All BHC newsBausch Health Companies peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ETONEton Pharmaceuticals Inc. | 54.88 | +0.20% | $1.57B | vs BHC |
| PAHCPhibro Animal Health Corporation Class A | 37.72 | +3.03% | $1.53B | vs BHC |
| CRONCronos Group Inc. | 3.24 | -1.37% | $1.19B | vs BHC |
| HROWHarrow Inc. | 30.62 | +0.89% | $1.15B | vs BHC |
| AMPHAmphastar Pharmaceuticals Inc. | 25.54 | -1.43% | $1.09B | vs BHC |
| PCRXPacira BioSciences Inc. | 25.20 | +1.78% | $1.00B | vs BHC |
| COLLCollegium Pharmaceutical Inc. | 21.93 | +0.23% | $713.94M | vs BHC |
| IRWDIronwood Pharmaceuticals Inc. Class A | 3.75 | +3.31% | $619.65M | vs BHC |
Indexes, lists and sector
Bausch Health Companies stock FAQ
What is Bausch Health Companies's stock price today?
BHC last traded at $6.15 as of Oct 7, 4:00 PM EDT, up 2.16% on the day. Prices are delayed at least 15 minutes.
Does Bausch Health Companies pay a dividend?
Yes. Bausch Health Companies pays $0.00 per share annually. The most recent dividend of $1.00 had an ex-dividend date of Nov 10, 2010.
When is Bausch Health Companies's next earnings date?
Bausch Health Companies is expected to report earnings on Wednesday, October 28, 2026. Analysts expect EPS of $1.08.
Who is Bausch Health Companies's CEO?
Mr. Thomas J. Appio is the chief executive officer of Bausch Health Companies Inc., which has about 20,300 employees.
Has BHC ever split its stock?
Yes. The most recent BHC stock split was a 2-for-1 split on Oct 16, 2000, one of 3 splits on record.
What is the BHC 52-week high?
The 52-week high for BHC is $8.00 and the 52-week low is $4.33. The stock is currently 23.1% below its high.